Serial Number
79370455
Owner
Skyline Therapeutics (Shanghai) Co.,Ltd.Attorney
Michael T. SmithFiling Date
Mar 2, 2023
CAPDRIVE Trademark
Serial Number: 79370455 • Registration: 7561433
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Michael T. Smith Birch Stewart Kolasch & Birch LLP
8110 Gatehouse Road, Suite 100E
Beijing Global Trade Center,
Falls Church, VA 22042
United States
Trademark Details
Filing Date
March 2, 2023
Registration Date
November 12, 2024
Published for Opposition
August 27, 2024
Goods & Services
Stem cells for medical purposes; biochemical medicine for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; biological preparations for medical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; chemico-pharmaceutical preparations for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the central nervous system; ophthalmological preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cardiovascular agents for medical purposes; cellular function activating agents for medical purposes; pharmaceutical products for the prevention and treatment of cancer
Scientific research and development; scientific research; technological research, namely, research on the subject of pharmaceuticals; biological research; scientific research in the nature of conducting clinical trials for others; medical research; pharmaceutical research services; research on the subject of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; structural and functional analysis of genomes; biotechnology research; analysis of the mode of action of chemical combinations on animals; research and development services in the field of antibodies; genetic testing for scientific research purposes; biological research and analysis; pharmaceutical drug development services; DNA screening for scientific research purposes; medical research; testing of pharmaceuticals; biomedical research services